These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34662892)

  • 1. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
    Carney BJ; Wang TF; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A; Neuberg D; Baumann Kreuziger L; Zwicker JI;
    Blood Adv; 2021 Dec; 5(24):5546-5553. PubMed ID: 34662892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
    Kopolovic I; Lee AY; Wu C
    Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
    Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort.
    Booth S; ; Desborough M; Curry N; Stanworth S
    J Thromb Haemost; 2022 Aug; 20(8):1830-1838. PubMed ID: 35505495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
    Squizzato A; Galliazzo S; Rancan E; Di Pilla M; Micucci G; Podda G; Valeriani E; Campiotti L; Bertù L; Ageno W; Porreca E; Lodigiani C
    Intern Emerg Med; 2022 Jan; 17(1):83-90. PubMed ID: 34110563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism.
    Lange N; Méan M; Stalder O; Limacher A; Tritschler T; Rodondi N; Aujesky D
    Thromb Res; 2019 May; 177():10-16. PubMed ID: 30826719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry).
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Watanabe H; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Am J Cardiol; 2018 Dec; 122(12):2131-2141. PubMed ID: 30293653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-Based Minireview: Full dose, modified dose, or no anticoagulation for patients with cancer and acute VTE and thrombocytopenia.
    Patell R; Zwicker JI
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):312-315. PubMed ID: 36485075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
    Lim MS; Enjeti AK
    Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.